- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03184649
Ibuprofen, Paracetamol Versus Placebo on Pain During Local Anesthetic Injection (RCT)
June 11, 2017 updated by: Rehab Abdelrahman Elshenawy, Cairo University
The Effect of Ibuprofen, Paracetamol Versus Placebo on Pain During Local Anesthetic Injection and Following Dental Extraction in Primary Molars: A Randomized Clinical Trial
The Effect of Ibuprofen, Paracetamol versus Placebo on Pain during Local Anesthetic Injection and Following Dental Extraction in Primary Molars: A Randomized clinical trial
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
1. Diagnosis:
- Diagnostic chart will be filled with personal, medical and dental history. DMF and def.
- Clinical examination (intra oral and extra oral) will be done by mirror and probe to assess the inclusion criteria. All materials will be packaged in sterilizations wraps and autoclave following the required bio safety standards.
2. Intervention:
Experimental Groups:
Group 1: Ibuprofen suspension (Ibufen®, 100 mg/5 mL; fruit flavored, orange colour, Abbott). Group 2: Paracetamol (Calpol™, 250 mg/5 mL; fruit flavored, orange color, GlaxoSmithKline).
Comparative Group:
Group 3: A fruit-flavored orange color placebo solution.
Clinical procedure:
- The drugs in all of the groups will be prepared in a fruit-flavored solution of the same color and scent.
- Patients will be blind to one of the three pre-treatment drug groups.
- Containers of each solution will be prepared and number-coded with the slips of paper by the assistant supervisor. The containers will be the same for all treatment groups except for the number coded with slips of paper.
- Both the researcher and the child/parent will be blind to the content of the container.
- The assigned solution will be taken by the patient at various times before administration of the local anesthetic agent. Ibuprofen 30 min before injection of local anesthesia paracetamol 60 min before injection of local anesthesia Placebo solution 60 min before injection of local anesthesia
- The time of the preoperative solution administration will be recorded on the data sheet.
- Topical anesthesia in the form of benzocaine gel 20% will be applied to the dried mucosa. All the children will be given 2% lidocaine with a 1:80,000 epinephrine injection for local anesthesia sufficient for obtaining adequate anesthesia.
- All teeth will be extracted with a minimum of surgical trauma in an uncomplicated fashion.
Recording data
- Pain scores will be recorded in the Pediatric Dental Clinic using a five-face scale that had been previously validated.
- This scale has shown good construct validity as a self-report pain measure. It measures an affective dimension of a child's pain experience after injection and teeth extraction and is used in children aged 7-12 years.
- It is easy to use and giving consistent scores from 0 to 4. It can be used for the subjective evaluation of feelings after the performance of painful dental procedures.
- The child will be shown to a set of five cartoon faces with varying facial expressions ranging from a smile/laughter to tears. The scores given are: (0) No sign of pain. (1) Mild pain. (2) Moderate pain. (3) Severe pain. (4) Very severe pain.
Study Type
Interventional
Enrollment (Anticipated)
52
Phase
- Phase 2
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt, 02
- Faculty of dentistry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 years to 12 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Children aged 7-12 years who need extractions under local anesthesia.
- Those having a parent/guardian to understand and comply with the requirements of the protocol and able to fill an appropriate written informed consent.
- Children and parents who agree to wait for the stipulated time before and after the extraction.
Exclusion Criteria:
- Children with acute pain.
- Patients taking analgesics within 5 hours prior to the dental extraction.
- Patients with a history of prolonged bleeding, platelet disorders, hypersensitivity, or allergic reactions to analgesics or any of the drugs tested.
- Patients without a home telephone or without parental supervision for the post- operative period.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: intervention arm
Ibuprofen suspension (Ibufen®, 100 mg/5 mL; fruit flavored, orange colour, Abbott) will be given 30 min before injection of local anesthesia.
Then pain scores will be recorded from 0-4.
|
It is a pre-analgesic will be taken before painful procedures.
Other Names:
|
|
Experimental: intervention
Paracetamol (Calpol™, 250 mg/5 mL; fruit flavored, orange color, GlaxoSmithKline) will be given 60 min before injection of local anesthesia.Then pain scores will be recorded from 0-4.
|
it is a pre-analgesic drug will be taken before painful procedure.
Other Names:
|
|
Placebo Comparator: comparator
A fruit-flavored orange color placebo solution will be given 60 min before injection of local anesthesia.Then pain scores will be recorded from 0-4.
|
orange juice as a comparative group.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
categorical score
Time Frame: 1 hour
|
mild, moderate, sever, very sever
|
1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
binary
Time Frame: 1 day
|
yes or no
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: fatma A. Elshehaby, Professor, Cairo University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2017
Primary Completion (Anticipated)
September 1, 2017
Study Completion (Anticipated)
December 1, 2017
Study Registration Dates
First Submitted
June 9, 2017
First Submitted That Met QC Criteria
June 9, 2017
First Posted (Actual)
June 12, 2017
Study Record Updates
Last Update Posted (Actual)
June 14, 2017
Last Update Submitted That Met QC Criteria
June 11, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Cyclooxygenase Inhibitors
- Antipyretics
- Acetaminophen
- Ibuprofen
Other Study ID Numbers
- RAElshenawy
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
i will be available after finished
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain Relief
-
Ain Shams UniversityCompleted
-
Wake Forest University Health SciencesCompleted
-
IRCCS Burlo GarofoloCompleted
-
Aalborg UniversityCompleted
-
Assiut UniversityCompleted
-
Assiut UniversityCompleted
-
Western Galilee Hospital-NahariyaWithdrawn
-
Assiut UniversityCompleted
Clinical Trials on Ibuprofen
-
Ondokuz Mayıs UniversityNot yet recruitingPostoperative Delirium | Cerebral Oxygen Saturation | Postoperative Cognitive Dysfunction (POCD)
-
Hamilton Health Sciences CorporationMcMaster University; Hamilton Academic Health Sciences OrganizationRecruitingPatent Ductus Arteriosus | PretermCanada
-
Ain Shams UniversityRecruitingNeonatal Prematurity | Patent Ductus Arteriosus in Preterm Infants | ProstaglandinsEgypt
-
University of Puerto RicoNot yet recruitingPost Operative Pain | Orthognathic SurgeryPuerto Rico
-
October University for Modern Sciences and ArtsRecruitingPain and Anxiety in Children With MIHEgypt
-
Bruno MinottiRoland Bingisser, Principal Investigator, Head of Emergency Department, University... and other collaboratorsCompleted
-
Armed Forces Institute of Dentistry, PakistanCompletedIrreversible Pulpitis | Root Canal Treatment | Post-endodontic PainPakistan
-
Benha UniversityNot yet recruitingPain After Extracorporeal Shock Wave Lithotripsy | PalmitoylethanolamideEgypt
-
Giresun UniversityCompletedPostoperative Analgesia | Laparoscopic HysterectomyTurkey (Türkiye)
-
Oman Medical Speciality BoardRecruitingPostoperative Pain | Trismus | Facial SwellingOman